‹ ›
MYP_025572
Basic Information
Abarelix
Anticancer
Hormonal / Endocrine ▸ Hormone peptide
not Standard
10 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XXXSXNLXPA
Physicochemical Analysis
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available

Not available: incomplete physicochemical profile.

Molecular Weight
Not available
Isoelectric Point (pI)
Not available
Net Charge (pH 7.0)
Not available
GRAVY Index
Not available
Boman Index
Not available
Instability Index
Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T15:38:33.224527+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0045722 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Acetylation
Amidation
Non-standard residues/X at 1, 2, 3, 5, 8
Bio-Activity Profile
GnRH antagonist Endocrine Anticancer
Healthy male subjects; luteinizing hormone suppression
0.00425 μg/mL
IC50
Clinical/Human: 0.22 d (5.3 h) for abarelix injectable solution and 13.2 d for abarelix depot injection
RECORD: Rec_0128704 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Acetylation
Amidation
Non-standard residues/X at 1, 2, 3, 5, 8
Bio-Activity Profile
GnRH antagonist Endocrine Anticancer
Healthy male subjects; dihydrotestosterone suppression
0.00342 μg/mL
IC50
Clinical/Human: 0.22 d (5.3 h) for abarelix injectable solution and 13.2 d for abarelix depot injection
RECORD: Rec_0177608 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Acetylation
Amidation
Non-standard residues/X at 1, 2, 3, 5, 8
Bio-Activity Profile
GnRH antagonist Endocrine Anticancer
Healthy male subjects; testosterone suppression
0.00208 μg/mL
IC50
Clinical/Human: 0.22 d (5.3 h) for abarelix injectable solution and 13.2 d for abarelix depot injection
RECORD: Rec_0384826 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
GnRH
9606;32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Acetylation
Amidation
Non-standard residues/X at 1, 2, 3, 5, 8
Bio-Activity Profile
GnRH antagonist Endocrine Anticancer
Healthy male subjects; follicle-stimulating hormone suppression
0.00643 μg/mL
IC50
Clinical/Human: 0.22 d (5.3 h) for abarelix injectable solution and 13.2 d for abarelix depot injection